Fig. 1From: Construction and validation of a predictive model for hepatocellular carcinoma based on serum markersPerformance of non-invasive predictive model for predicting the onset of HCC in Changzhou cohort. A ROC curve analysis of the risk model and single variable for predicting the onset of HCC. B ROC curve analysis of the risk model and other score systems for predicting the onset of HCC. C ROC curve analysis of the risk model for predicting the onset of HCC in patients with different AJCC TNM stages. D Decision curve analysis demonstrates the clinical net benefit of the risk score model and other score systems for the onset of HCC in Changzhou cohort. E Clinical impact curve of the risk model. F Cumulative event between high risk and low risk groups at indicated time before clinical diagnosisBack to article page